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Tourette’s syndrome consists of multiple motor tics
and one or more phonic tics. It is a chronic neuro-
psychiatric disorder characterized by a waxing and
waning course. Its onset is in childhood and the
prevalence is 4–5 per 10,000 people [1]. Patients with
Tourette’s syndrome commonly show a wide range
of co-occurring psychiatric and behavioral disorders,
including attention-deficit hyperactivity disorder,
obsessive-compulsive symptoms, anxiety and affective
disorders [2].
Compared with Tourette’s syndrome, which fre-
quently occurs during childhood and adolescence,
bipolar disorder is typically diagnosed during late
adolescence or adulthood. A lifetime prevalence of
5.0% and a 12-month prevalence of 3.4% have been
reported for DSM-IV (Diagnostic and Statistical Manual
of Mental Disorders, 4th edition) bipolar spectrum dis-
order among 12–29-year-olds [3]. Mood swings and
anger are some of the comorbid psychiatric manifes-
tations that frequently occur in patients with Tourette’s
syndrome [4]. Although the sample sizes of previous
studies have been small, and controversy surrounds
the definition of mania in children and adolescents,
the results suggest a relationship between Tourette’s
syndrome and bipolar disorder [2,5–8]. Comings and
Comings reported a controlled study in which none
of the patients without Tourette’s syndrome had
mania; however, 19.1% of the patients with Tourette’s
syndrome had comorbid mania [4]. Spencer et al also
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Changes in moods are one of the comorbid psychiatric manifestations that frequently occur in
patients with Tourette’s syndrome. The assessment of a manic episode in children with Tourette’s
syndrome is challenging. Furthermore, the treatment of children with comorbid mania and
Tourette’s syndrome has not been extensively studied. We present a 10-year-old boy who suf-
fered from both Tourette’s syndrome and mania, whose symptoms improved after using lithium
and risperidone. The child was diagnosed with Tourette’s syndrome at 7 years of age when he
suffered from tics and experienced his first manic episode. He received monotherapy, including
haloperidol, risperidone and aripiprazole, and the response was poor. When the combination of
lithium and risperidone was used, the tics and mania subsided. It is important to assess individ-
uals with Tourette’s syndrome for associated bipolar disorder. The treatment of children with
both disorders is a major clinical issue, and our case may serve as an example for successful 
treatment strategies.
Key Words: bipolar disorder, child, Tourette’s syndrome
(Kaohsiung J Med Sci 2009;25:608–12)
Tourette’s syndrome and bipolar disorder in a child
Kaohsiung J Med Sci November 2009 • Vol 25 • No 11 609
found higher rates of bipolar disorder in a group of
children with chronic tic disorders (28%) than in those
with Tourette’s syndrome (13%) or in a healthy control
group (0%) [9].
Emotional excitement and tension associated with
interpersonal relationships that result from symptoms
of mania may aggravate the symptoms of tics [10]. On
the other hand, tics may result in serious social con-
sequences and academic problems for the patient,
which may precipitate or perpetuate the mania [11].
A vicious cycle may develop in patients with comor-
bid Tourette’s syndrome and bipolar disorder, when
neither of the disorders are managed by interventions.
Classic manic episodes are uncommon in prepubes-
cent children; however, prepubescent children exhibit-
ing symptoms of mania often require hospitalization.
Reviews of current therapeutic approaches have re-
vealed several treatment options for patients with
Tourette’s syndrome [12]. Nevertheless, to the best of
our knowledge, treatments for mania in children and
adolescents have not been well studied, and research
regarding the treatment of children and adolescents
with comorbid mania and Tourette’s syndrome has
not been reported. In this case report, we describe the
diagnostic process and successful therapeutic inter-
vention used in a 10-year-old boy with comorbid
Tourette’s syndrome and bipolar disorder.
CASE PRESENTATION
Chief problems
The patient was a 10-year and 7-month-old boy who
was brought to the Department of Child and
Adolescent Psychiatry of a mental hospital because
of irritability, labile and euphoric mood, and violent
behaviors observed 2 months before admission.
Family history
The patient lived with his parents and was the only
child in his family. His father is a doctor and his mother
is unemployed. There was no family history of tics.
However, his uncle’s son had been diagnosed with
bipolar disorder.
History of physical illness
There was no history of head injury or infections of
the central nervous system. The medical history of
his birth and development were unremarkable.
History of psychiatric illness
Reviewing his medical history, he had normal devel-
opmental milestones. His premorbid personality was
introverted and assiduous. There had been no diffi-
culties in sustaining attention or controlling his behav-
ior prior to this admission. No depressive or manic
episodes were found. His performance at school was
good. When he was 5 years old, involuntary protrusion
of the tongue from the mouth developed, although it
remitted spontaneously 1 month after it began. At the
age of 7 years, he suffered from the same involuntary
behavior and new involuntary movements, includ-
ing shoulder shrugging, head flinging and teeth gnash-
ing, developed subsequently. Vocal tics and grunting
also emerged. Brain magnetic resonance imaging was
performed at that time and revealed unremarkable
findings. The tics were mitigated by haloperidol, 
but he could not tolerate the sedative effects of the 
treatment. Pergolide (0.5 mg/day) was used as a
replacement, and the symptoms remitted for 1 year.
When he was 10 years old, he went to the 5th
grade, where he met some new classmates. The tics
began again, and irritability became more severe
with time. In addition, the patient was increasingly
absent from school and his school performance wors-
ened. These problems were initially attributed to reac-
tions to the interpersonal tension secondary to his tics.
Pergolide was used to relieve the tics, but the response
was poor. Amisulpride (200 mg/day), risperidone
(2 mg/day) and haloperidol (1.125 mg/day) were
also used as monotherapy to mitigate the tics. How-
ever, none of these monotherapies were effective. A
combination of risperidone (2 mg/day) and cloni-
dine (0.5 mg/day) was then given, but the symptoms
did not improve substantially using this therapy.
At the same time, his parents noticed that his
mood was not only irritable but also labile and
euphoric. He jumped from the balcony of the second
floor of the classroom building twice because he was
angry at his classmates for paying attention to his tics.
He thought that he would not get hurt by jumping
from the second floor because he believed he had a
“special power helping him”. In fact, he suffered a
lower leg fracture. Therefore, it was suggested that
he receive inpatient care and he was admitted to 
the psychiatric ward of a medical center. Crisis inter-
vention was done under the tentative diagnosis of
Tourette’s syndrome. Because of his poor responses
to haloperidol, risperidone and clonidine, aripiprazole
(5 mg/day) was prescribed and the tics seemed to
mildly improve during the 5 days of hospitalization.
After discharge, he moved to a different classroom
because of the poor relationships with the original
classmates. However, his irritability, euphoria and
aggressive behaviors did not subside, but instead
became progressively more severe. He was readmitted
due to the worsening conditions 1 month after the
previous admission, and the dose of aripiprazole was
increased to 15 mg/day. Because the irritability and
euphoria did not improve, he was transferred to the
Department of Child and Adolescent Psychiatry of a
mental hospital for help and was admitted to the
acute ward.
A manic episode was strongly suspected because
of the sustained euphoria, expansive mood and 
irritability. To establish a differential diagnosis, we
stopped all of the medications, except for clonazepam
(2 mg/day), which was prescribed as a sleep aid. The
patient’s mood became more and more irritable and
elevated, and he became more talkative than usual and
had a decreased need for sleep. Goal-directed activi-
ties, such as social interactions, were increased. The
manic symptoms persisted for more than 1 week under
clonazepam therapy, and a manic state was diagnosed.
Results of examination at this admission
Awake-electroencephalography revealed no polyspike
waves, and thyroid function was within reference
range. The Wechsler Intelligence Scale for Children–
Third Edition (WISC-III), which was done when the
mania subsided, revealed his IQ to be 102, which was
within the average range.
Treatment
Lithium was prescribed and the dosage gradually
increased to 700 mg/day. Risperidone (2 mg/day) was
prescribed simultaneously, but the manic and tic symp-
toms showed only mild improvements with these
medications. Then, the dose of lithium was increased
to 1,200 mg/day to increase the blood concentration
level to 0.9 mmol/L, and the dose of risperidone was
unchanged. The mood was less elevated about 1
week after starting the new treatment. The irritability
and decreased need for sleep progressively remitted.
At the same time, the tics also improved. No side-
effects of these medications emerged during the ad-
mission or follow-up. He was discharged and he
returned to school. He has been treated with lithium
(1,200mg/day) and risperidone (2mg/day) in the out-
patient clinic for 6 months. No further manic symp-
toms developed with these medications. The severity
of the tics did not worsen.
DISCUSSION
The case described here illustrates the complex nature
and treatment of a child with comorbid Tourette’s
syndrome and bipolar disorder. Until now, the rela-
tionship between Tourette’s syndrome and bipolar
disorder has remained unclear. Kerbeshian et al
reported that the 16q22-23 region should be consid-
ered as a candidate region for primary or modifying
genetic factors resulting in the phenotypes of Tourette’s
syndrome and bipolar disorder [13]. It has also been
proposed that a gene leading to the expression of
Tourette’s syndrome may represent a locus for bipo-
lar disorder [14]. Although the locus proposed by
Comings and Comings has not been supported by
further studies [4], the general concept may have
merit. Both Tourette’s syndrome and bipolar disorder
appear to share a number of neurophysiological char-
acteristics, including abnormalities in noradrenergic,
dopaminergic, and serotonergic neurotransmission
[2]. More research is needed to elucidate why bipolar
disorder may be overrepresented in patients with
Tourette’s syndrome. On a more practical level, clini-
cians should be alert to the possible coexistence of
Tourette’s syndrome and bipolar disorder. This may
have significant implications for effective treatment,
such as the need for hospitalization.
The assessment of manic symptoms in a child
with Tourette’s syndrome is challenging. The distress
resulting from the tics may make children irritable,
impulsive and agitated. Symptoms of mania may also
include irritability, impulsiveness and psychomotor
agitation. This explains why it is difficult to assess
manic symptoms in a child with Tourette’s syndrome.
Leibenluft et al [15] suggested that clinicians are able
to confirm the diagnosis of mania in juvenile patients
when euphoria, grandiosity, a decreased need for
sleep or increased goal-directed activities are identi-
fied because these symptoms are specific to the diag-
nosis of mania but not to Tourette’s syndrome. The
present case suffered from euphoria, grandiosity, a
decreased need for sleep and increased goal-directed
activities on days without psychotropic medications.
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The manic episode lasted for more than 1 week; there-
fore, the symptoms were consistent with the diagnosis
of mania.
Several researchers have reported on many kinds
of treatments for tics, including pharmacotherapy and
non-pharmacotherapy [16–18]. Treatments for comor-
bid conditions are also important to mitigate tics.
However, treatments for mania in children and ado-
lescents have not been well studied, and there have
been few studies on the treatment of Tourette’s syn-
drome and mania. Kerbeshian et al reported that the
frequency and intensity of motor and vocal tics was
mood-dependent, with exacerbations during the pres-
ence of manic symptoms [13]. Therefore, it would be
ineffective to treat the tics only and not the mania, or,
if the treatments were only focused on mania, the
conditions might not be completely relieved.
Aripiprazole was reported to be effective in treating
Tourette’s syndrome and mania [19,20]. However, our
patient received 15mg/day of aripiprazole but neither
his tics nor manic symptoms were relieved. Our patient
was then given the combined treatment of lithium and
risperidone, which simultaneously relieved the symp-
toms of tics and mania, and interrupted the vicious
cycle between mania and Tourette’s syndrome.
Our patient did not experience obvious side effects
of lithium or risperidone. Lithium is approved by the
United States of America Food and Drug Adminis-
tration to treat individuals with acute mania aged 
12 years or above, whereas risperidone is approved
for adult mania. Further investigations are needed on
the use of lithium and risperidone in the treatment 
of children with bipolar disorder and Tourette’s syn-
drome. Our case offers an example for children with
both diseases. The safety and drug-related side-effects
should be closely monitored because they have not
been well studied in children.
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情緒症狀是妥瑞氏症個案常伴隨的問題之一，因此，在這些個案中評估是否有躁症發
作，深具挑戰性，而治療同時有躁症及妥瑞氏症的兒童也尚未被詳細研究。以下報告
一個年紀 10 歲而同時有妥瑞氏症及躁症、經 lithium 及 risperidone 治療成功的個
案。個案 7 歲時被診斷為妥瑞氏症，在 10 歲時遭遇第一次躁症發作且合併有妥瑞氏
症。個案曾接受過 haloperidol，risperidone 及 aripiprazole 等單一藥物治療，但
效果不佳，在合併 lithium 及 risperidone 治療下，其臨床症狀有明顯改善。評估妥
瑞氏症患者中是否有合併躁鬱症具有重要性，而如何處理同時有躁鬱症及妥瑞氏症的
兒童，是臨床上的重要議題。我們提出的報告可做為未來持續研究的基礎。
關鍵詞：雙極性情緒疾病，兒童，妥瑞氏症
(高雄醫誌 2009;25:608–12)
